Loading clinical trials...
Loading clinical trials...
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Karolinska Institutet
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT06814496 · Melanoma, Medullary Thyroid Cancer, and more
NCT06157151 · Cervical Cancer, HPV-Related Carcinoma, and more
NCT06952660 · Cervical Cancer
NCT06527456 · Cervical Cancer
Region of Skåne
Lund, Skåne County
Region Stockholm
Stockholm
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions